Regeneron purchases Sanofi’s stake in Libtayo collaboration

Regeneron purchases Sanofi’s stake in Libtayo collaboration

Source: 
Biopharma Reporter
snippet: 

Regeneron Pharmaceuticals will purchase Sanofi's stake in their collaboration on Libtayo (cemiplimab) for an upfront payment of $900m, giving Regeneron exclusive worldwide rights to the medicine.